the NHS question that gets asked weekly, answered properly
the NHS question that gets asked weekly, answered properly, which sounds obvious until you try to state the evidence for it.
Concentrations can differ between products and between pharmacies. Switching mid-titration means redoing the arithmetic rather than carrying the old unit count across.
GP said no in the spring, specialist said yes eighteen months later. Same person, same numbers.
Four pharmacies, four prices, same product, same month. The spread was larger than I expected and none of them were the headline offer.
If somebody has the same thing measured a different way, post it next to mine and we will see whether they agree.
best — the order this archive was captured in
A private prescription is an independent route: it does not affect NHS list position, and it is not a step in the same pathway.
Read the MHRA notice rather than the news coverage and the actual scope was much narrower than the panic threads suggested.
Two years and four months on a tier 3 list. Referral date and every letter kept, which turned out to matter when the service reorganised.
Discharge from a specialist service at goal is a normal end point of that pathway. Whether prescribing continues in primary care afterwards is a local decision and is worth asking about at the start rather than at the end.
Pharmacy staff name removed. The pharmacy itself can be named in a pricing post.
Agreed. The ICB variation is the thing that makes national advice useless here.
Discharge from a specialist service at goal is a normal end point of that pathway.
Adding the practical bit — ask what happens at discharge before you start, not after.
Scotland, Wales and Northern Ireland have their own arrangements. An answer that begins with "in England" should say so, and most of the confusion here comes from answers that do not.
the ICB decides the threshold and they are not the same across England
Disagree. That is the pathway in one ICB and it does not generalise even to the next one over.